Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population

Citation
M. Murata et al., Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population, CANCER LETT, 165(2), 2001, pp. 171-177
Citations number
29
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
165
Issue
2
Year of publication
2001
Pages
171 - 177
Database
ISI
SICI code
0304-3835(20010426)165:2<171:GPICP(>2.0.ZU;2-Z
Abstract
Associations between genetic polymorphisms of CYP1A1, CYP1A2, CYP2E1, GSTM1 and GSTT1 and prostate cancer (PCa) were analyzed in a case-control study of 315 individuals. The frequency of valine (Val)/valine (Val) genotypes fo r CYP1A1 was 11.3% in cases compared with 5.5% in controls, this polymorphi sm thus being associated with a significantly increased risk of PCa (odds r atio = 2.4, 95% confidence interval (CI) = 1.01-5.57). No links were detect ed between PCa and polymorphisms in other enzymes. However, the combination of CYP1A1 (Ile/Val and/or Val/Val) polymorphisms with the GSTM1 null type resulted in an OR of 2.2 (CI = 1.10-4.57, 1.12-4.20, respectively). This st udy suggests that the CYP1A1 polymorphism and its combination with GSTM1 ma y be associated with PCa susceptibility in the Japanese population. (C) 200 1 Elsevier Science Ireland Ltd. All rights reserved.